| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/07/2010 | EP2171053A1 Natriuretic polypeptides |
| 04/07/2010 | EP2170946A2 B7-dc variants |
| 04/07/2010 | EP2170941A2 Preprocalcitonin antigen t epitopes |
| 04/07/2010 | EP2170938A1 Rtef-1 variants and the use thereof for inhibition of angiogenesis |
| 04/07/2010 | EP2170932A1 Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ards) and clinical disorders associated with therewith |
| 04/07/2010 | EP2170930A2 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 04/07/2010 | EP2170929A2 Peptides facilitating retrograde transport and their uses |
| 04/07/2010 | EP2170400A1 Pharmaceutical liquid composition of botulinum toxin with improved stability |
| 04/07/2010 | EP2170393A2 Antithrombotic agents and methods of use thereof |
| 04/07/2010 | EP2170392A2 Composition and method for treatment of autoimmune disease |
| 04/07/2010 | EP2170375A1 Process for providing a temperature - stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin in solid form |
| 04/07/2010 | EP2170374A2 Method for treating diseases related to mitochondrial dysfunction |
| 04/07/2010 | EP2170372A1 Leishmania sterol 24-c-methyltransferase compositions for the prevention, treatment and diagnosis of leishmaniasis |
| 04/07/2010 | EP2170370A2 Recombinant transferrin mutants |
| 04/07/2010 | EP2170368A1 Liquid protein formulations comprising gdf-5 for use at elevated temperatures |
| 04/07/2010 | EP2170367A2 Gbp, compositions comprising gbp, and related methods and uses thereof |
| 04/07/2010 | EP2170364A2 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 04/07/2010 | EP2170363A2 Tissue specific peptide conjugates and methods |
| 04/07/2010 | EP2170362A1 Lyophilized anti-fungal composition |
| 04/07/2010 | EP2170361A2 Treatment and prevention of inflammatory diseases and autoimmune diseases |
| 04/07/2010 | EP2170312A1 Method of preventing and treating acute brain pathologies |
| 04/07/2010 | EP2170276A1 Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
| 04/07/2010 | EP2170270A2 Compositions for delivering medicaments into the lungs, uses thereof |
| 04/07/2010 | EP2170083A2 Mitogen activated protein kinase modulator |
| 04/07/2010 | EP1830818B1 Process for the manufacture of sterile suspensions or lyophilisates of low-soluble basic peptide complexes, pharmaceutical formulations comprising these complexes and their use as medicament |
| 04/07/2010 | EP1423150B1 Sustained release of microcrystalline peptide suspensions |
| 04/07/2010 | EP1322752B1 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof |
| 04/07/2010 | EP1313499B1 Method for treating the central nervous system by administration of igf structural analogs |
| 04/07/2010 | EP1255824B1 Transgenic mice for the study of neurodegenerative syndromes |
| 04/07/2010 | EP1254237B1 Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| 04/07/2010 | EP1240331B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 04/07/2010 | EP1175497B1 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 04/07/2010 | EP1121155B1 Site-directed dual pegylation of proteins |
| 04/07/2010 | CN1769298B Fusion protein with antitumour action and its coding gene and uses |
| 04/07/2010 | CN1703524B Genes and polypeptides relating to human pancreatic cancer |
| 04/07/2010 | CN1578647B Implantable and sealable system for unidirectional delivery of therapeutic agents to tissues |
| 04/07/2010 | CN1545551B Human monoclonal antibody against hepatitis C virus E2 glycoprotein |
| 04/07/2010 | CN101691580A Novel fusion protein for human HMGB1 A box and acidic tail and use thereof |
| 04/07/2010 | CN101691400A Method for solid phase synthesis of bitter gourd MC-JJ2622 peptide analogs under microwave irradiation and application of bitter gourd MC-JJ222 peptide analogs |
| 04/07/2010 | CN101691399A Method for solid phase synthesis of bitter gourd MC-JJ6221 peptide analogs under microwave irradiation and application of bitter gourd MC-JJ6221 peptide analogs |
| 04/07/2010 | CN101691398A Method for solid phase synthesis of bitter gourd MC-JJ2162 peptide analogs under microwave irradiation and application of bitter gourd MC-JJ2162 peptide analogs |
| 04/07/2010 | CN101691395A Method for solid phase synthesis of bitter gourd MC-JJ62 peptide analogs under microwave irradiation and application of bitter gourd MC-JJ62 peptide analogs |
| 04/07/2010 | CN101691394A Method for solid phase synthesis of bitter gourd MC-JJ6 peptide analogs under microwave irradiation and application of bitter gourd MC-JJ6 peptide analogs |
| 04/07/2010 | CN101690815A Novel use of dipeptidyl peptidase-iv inhibitor |
| 04/07/2010 | CN101690804A Medicinal preparations for treating cerebral diseases by transtympanic administration |
| 04/07/2010 | CN101690803A Medicinal preparations for treating inner ear diseases by transtympanic administration |
| 04/07/2010 | CN101690802A Cervical mucosa inducing gel |
| 04/07/2010 | CN101690801A Application of interleukin-1 receptor antagonist and medicinal composition thereof |
| 04/07/2010 | CN101690716A Calcium alginate-chitosan sustained-release microsphere carrying growth hormone and application thereof |
| 04/06/2010 | US7691992 Nucleic acids encoding the human ALEX1 protein |
| 04/06/2010 | US7691990 Employs a procedure in which a DNA intercalator contained in liquid or gas is selectively adsorbed onto DNA by contacting the DNA with the DNA intercalator; capable of selectively adsorbing dioxin and dioxin-like substances with high efficiency and of easily enhancing throughput |
| 04/06/2010 | US7691989 Methods for producing soluble membrane-spanning proteins |
| 04/06/2010 | US7691981 Reducing cell proliferation in mammals; antitumor agents; endothelial growth factors; Fab, F(ab')2, and Fv fragments |
| 04/06/2010 | US7691976 BRAF35 protein and BRCA2/BRAF35 complex and methods of use |
| 04/06/2010 | US7691975 Interferon-β complex |
| 04/06/2010 | US7691974 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 04/06/2010 | US7691968 Process for the synthesis of peptides amides by side-chain attachment to a solid phase |
| 04/06/2010 | US7691967 Smart pro-drugs of serine protease inhibitors |
| 04/06/2010 | US7691965 Helical synthetic peptides that stimulate cellular cholesterol efflux |
| 04/06/2010 | US7691964 Contact Inhibitory Factor (CIF) mediated inhibition of tumor metastasis and angiogenesis |
| 04/06/2010 | US7691963 or exendin-4 agonists covalently bonded to albumin, polyethylene glycol, gelatin, (hydroxypropyl)-methacrylamide, a polyamino acid, fatty acid, polysaccharide, dextran to increase molecular size; diabetes, postprandial dumping syndrome, postprandial hyperglycemia, dyslipidemia, obesity; renal filtration |
| 04/06/2010 | US7691962 Chemical linkers and conjugates thereof |
| 04/06/2010 | US7691906 comprises fatty acids; for treatment/prevention of sepsis or inflammatory shock |
| 04/06/2010 | US7691839 Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation |
| 04/06/2010 | US7691829 An aqueous eye drop solution of hydrolyzed collagen to promote and protect tissue and cell growth, reduce scar tissue and repair connective tissues; wound healing agents; bandages; carriers preferably combined with hyaluronic acid or a salt, a polysulfated glycosaminoglycan and/or a glucosamine salt |
| 04/06/2010 | US7691823 RIP140 regulation of glucose transport |
| 04/06/2010 | US7691822 Methods and compositions for treatment of interferon-resistant tumors |
| 04/06/2010 | US7691819 Buffer intracellular reduction and oxidation for the stressed cells in various disease states; beneficial as adjunctive support therapy, multiple chemical sensitivity syndrome, Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Roussy-Levy syndrome, Rosenberg Chutorian syndrome, Korsakoff syndrome |
| 04/06/2010 | US7691818 Identified new isostere of the dipeptide phenylalanine-proline (Phe-Pro) having four stereogenic centers on which compounds are based; enzyme inhibitors; viricides; HIV; post-exposure prophylaxis and as infection therapy |
| 04/06/2010 | US7691817 System and method for inhibiting cellular proliferation with tachykinins |
| 04/06/2010 | US7691816 a mixture of transforming growth factor and sugar selected from maltose, sucrose, glucose or mannose, used as wound healing and antiscarring agents |
| 04/06/2010 | US7691815 Methods for blocking TNF-alpha activity in mammals with trimeric soluble TNF receptors |
| 04/06/2010 | US7691814 Osteogenic compositions comprising an amino acid sequence capable of being phosphorylated by CAMK2 |
| 04/06/2010 | US7691813 Cyclic peptide CXCR4 antagonists |
| 04/06/2010 | US7691812 Methods for inhibiting growth of prolactin-responsive cancer cells with cyclosporine A or other cyclophilin inhibitors |
| 04/06/2010 | US7691811 Enhancing the activity and/or duration of action of soft anti-inflammatory steroids such as loteprednol etabonate with a synergistic amount of another steroid such as cortisone |
| 04/06/2010 | US7691810 Method of producing recombinant antithrombin III composition |
| 04/06/2010 | US7691809 For treatment or prevent of autoimmune, neurodegenerative and immune hypersensitivity disorders such as Alzheimer's disease, multiple sclerosis, rheumatoid arthritis, allergy, stroke or chronic fatigue syndrome |
| 04/06/2010 | US7691808 Use of Slurp-1 for treating diseases related to acetylcholine receptor dysfunction |
| 04/06/2010 | US7691807 Hybrid oligomers, their preparation process and pharmaceutical compositions containing them |
| 04/06/2010 | US7691806 Mixture of protein polymer and active materials |
| 04/06/2010 | US7691805 Antimicrobial compounds |
| 04/06/2010 | US7691804 Administering formulation selected from a BAFF-R polypeptide or fragment; a chimeric molecule comprising a BAFF-R polypeptide or fragment fused to heterologous amino acid sequence; anti-BAFF-R antibody for inhibiting B-cell growth |
| 04/06/2010 | US7691610 Vectors and host cells for Zven biodrug production; agents that stimulate gastrointestinal contractility, gastric emptying, intestinal transit, and treating gastroparesis |
| 04/06/2010 | US7691606 Soluble GDNFR (Glial-cell Derived Neurotrophic Factor) that retains both ligand binding, and receptor signaling function (via Ret receptor tyrosine kinase) used to impart, restore, or enhance GDNFR alpha -ligand (preferably GDNF) responsiveness to cells; kidney diseases |
| 04/06/2010 | US7691603 Intracellular formation of peptide conjugates |
| 04/06/2010 | US7691593 Regulation of lung tissue by patched therapeutics and formulations and uses related thereto |
| 04/06/2010 | US7691591 Methods of identifying and isolating cells expressing DC-sign |
| 04/06/2010 | US7691590 Reducing myelin-mediated inhibition of axon regeneration |
| 04/06/2010 | US7691585 Human Zven polypeptides |
| 04/06/2010 | US7691567 Fortilin binds p53 and prevents apoptosis; fortilin inhibitor select from the group, polypeptide, an antibody, monoclonal antibody, nucleic acid molecule, antisense molecule or a ribozyme |
| 04/06/2010 | US7691412 dissolving active principle in water; emulsifying resulting solution of active principle with d,l-lactide-co-glycolide matrix copolymer, emulsifying first emulsion in external aqueous phase containing surfactant, viscosity-enhancing agent, osmotic agent, extraction-evaporation to form microspheres |
| 04/06/2010 | US7691408 Composition having gelling properties for the prolonged delivery of bioactive substances |
| 04/06/2010 | US7691394 High-potency botulinum toxin formulations |
| 04/06/2010 | US7691390 polypeptide and isolated nucleic acid encoding the polypeptide for SARS CoV protein 3a, which can serve as a target for elucidating the mechanisms of SARS and developing vaccines and therapeutics |
| 04/06/2010 | US7691385 Polypeptides encoded by polynucleotides that are useful for detecting resistance to streptogramin A or to streptogramin B and related compounds |
| 04/06/2010 | US7691382 Antiviral polypeptides comprising tandem repeats of APOE 141-149 and variants thereof |
| 04/06/2010 | US7691380 Coagulating the vascular systems of cancer cells through site specific delivery of coagulant antibodies causing regression of the cells |
| 04/06/2010 | US7691378 Treating carcinomas or adenocarcinomas using at least one anti-TNF (tumor necrosis factor) antibody |
| 04/06/2010 | US7691371 Preparation comprising batroxobin for inhibiting local invasion of malignant tumors |